At the 19th Conference on Retroviruses and Opportunistic Infections (CROI) on Wednesday, Gabriel Chamie of the University of California, San Francisco “discussed outcomes in a routine linkage-to-care strategy versus and an enhanced strategy for accelerated antiretroviral therapy (ART) start in rural Uganda,” the Center for Global Health Policy’s “Science Speaks” blog reports. In the study, a higher percentage of people who were offered the enhanced strategy received follow-up care, began ART, and remained in care, and “Chamie highlighted the need for enhanced linkage to care efforts for patients at all CD4 cell counts,” according to the blog (Mazzotta, 3/7).